KSIĄŻKI POWIĄZANE ZE SŁOWEM «LIPOPROTEÍNĂ»
Poznaj użycie słowa
lipoproteínă w następujących pozycjach bibliograficznych Książki powiązane ze słowem
lipoproteínă oraz krótkie ich fragmenty w celu przedstawienia kontekstu użycia w literaturze.
1
Lipoprotein (a) - Pagina 50
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J. Lipid Res. 26, 1314—1323. Bersot, T. P., Innerarity, T. L., Pitas, R. E., Rall, S. C., Weisgraber, K. H., and Mahley, ...
2
Factores metabólicos 1. Homocisteína, Lipoproteína: ... - Pagina 609
Control global del riesgo cardiometabólico José Sabán Ruiz. Factores. metabólicos. I. Homocisteína,. lipoproteína. (a). O. Sánchez, R. Fabregate, J. Sabán Colección: Monografías Serie: MEDICINA/ CIENCIAS DE LA SALUD Otros títulos ...
3
Neurology and General Medicine - Pagina 1159
A graded response has been reported between the degree of carotid atherosclerosis and lipoprotein (a) levels.28,29,35,36 Numerous studies have linked high serum lipoprotein (a) levels to cerebrovascular disease and stroke. Shintani and ...
Michael Jeffrey Aminoff,
2008
4
Clinical Lipidology: A Companion to Braunwald's Heart Disease
Anglés-Cano E, de la Peña Díaz A, Loyau S: Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci 2001;936: 261–275. 103. Knapp JP, Herrmann W: In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and ...
Christie M. Ballantyne,
2009
5
Handbook of Lipoprotein Testing - Pagina 381
Lipoprotein(a) and coronary heart disease risk. Curr Cardiol Rep 1999;1:105-111. 246. Dahlen GH, Weinehall L, Stenlund H, et al. Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A1 protects against primary acute ...
Nader Rifai, G. Russell Warnick, Marek H. Dominiczak,
2000
6
Clinical Lipidology: A Companion to Braunwald's Heart ... - Pagina 126
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. Biochim Biophys Acta 2005;1687:1–10. Kapetanopoulos A, Fresser F, Millonig G, et al ...
Christie M. Ballantyne,
2014
7
Handbuch der Fettstoffwechselstörungen: ... - Pagina 216
Dyslipoproteinämien und Atherosklerose: Diagnostik, Therapie und Prävention Peter Schwandt. 4.4 Lipoprotein(a) Hans Georg Kraft und Gerd Utermann 4.4.1 Einleitung 216 4.4.2 Struktur und Stoffwechsel von Lipoprotein(a) 217 ...
8
Therapeutic Lipidology - Pagina 266
High-level lipoprotein(a) expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein(a) but not in low density lipoproteins. J Lipid Res 2005;46:769–78. Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, ...
Michael Davidson, Peter P. Toth, Kevin C Maki,
2007
9
Fibrinolysis in Disease - The Malignant Process, ...
Jauhianen, M., Metso, J., Koskinen, P., and Ehnholm, C., Characterization of the enzyme activity of human plasma lipoprotein(a) using synthetic peptide substrates, Biochem. J. 274, 491, 1991. Chulkova, T.M., Enzymatic properties of active ...
10
The John Hopkins Textbook of Dyslipidemia - Pagina cl
Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41:246–255. Genest J Jr, McNamara JR, Ordovas JM, et al. Lipoprotein cholesterol, apolipoprotein A-I and B ...
Peter O. Kwiterovich,
2012